RSPO2 Antikörper (AA 190-218)

Produktnummer ABIN7871604

Der Kaninchen Polyklonal anti-RSPO2 Antikörper wird verwendet zum Nachweis von RSPO2 in Proben von Human. Er wurde validiert für WB, FACS und IHC (p).

Kurzübersicht für RSPO2 Antikörper (AA 190-218) (ABIN7871604)

Target: RSPO2 (R-Spondin 2 (RSPO2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RSPO2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-RSPO2 Antikörper

Bindungsspezifität: AA 190-218

Verwendungszweck: RSPO2 Antibody / R-spondin-2

Aufreinigung: Antigen affinity

Immunogen: A portion of amino acids 190-218 from the human protein was used as the immunogen for this RSPO2 antibody.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: The stated application concentrations are suggested starting amounts. Titration of the RSPO2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4oC for up to one month. For long term, aliquot the RSPO2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu RSPO2

Target: RSPO2 (R-Spondin 2 (RSPO2))

Andere Bezeichnung: RSPO2

Hintergrund: RSPO2 is a member of the R-spondin family of proteins, which are known for their ability to regulate the Wnt signaling pathway. This pathway plays a crucial role in cell proliferation, differentiation, and stem cell maintenance. RSPO2 specifically has been shown to enhance Wnt signaling, leading to increased cell growth and tissue regeneration. Research on RSPO2 is still in its early stages, but some studies have already shown promising results. For example, a study published in the journal Cell Stem Cell found that RSPO2 can enhance the regenerative capacity of intestinal stem cells, potentially leading to new treatments for diseases like inflammatory bowel disease.

UniProt: Q6UXX9